UMIN ID: UMIN000001993
Registered date:21/05/2009
Effects of rosuvastatin and ezetimibe on bone turnover markers in type 2 diabetes patients with hypercholesterolemia
Basic Information
| Recruitment status | Complete: follow-up complete |
|---|---|
| Health condition(s) or Problem(s) studied | hypercholesterolemia with type 2 diabetes |
| Date of first enrollment | 2008/12/01 |
| Target sample size | 40 |
| Countries of recruitment | Japan |
| Study type | Interventional |
| Intervention(s) | Rosuvastatin Ezetimibe |
Outcome(s)
| Primary Outcome | Bone turnover markers |
|---|---|
| Secondary Outcome |
Key inclusion & exclusion criteria
| Age minimum | Not applicable |
|---|---|
| Age maximum | Not applicable |
| Gender | Male and Female |
| Include criteria | |
| Exclude criteria | Nobody had hepatic or renal dysfunction or nutritional derangements. All patients were free of drugs known to influence bone and calcium metabolism, such as vitamin D, bisphosphonate, or estrogen, up until the time of the study. Nobody had treatments with any cholesterol lowering agent. |
Related Information
| Primary Sponsor | Department of Internal Medicine 1, Shimane University School of Medicine |
|---|---|
| Secondary Sponsor | |
| Source(s) of Monetary Support | Department of Internal Medicine 1, Shimane University School of Medicine |
| Secondary ID(s) |
Contact
| public contact | |
| Name | |
| Address | Japan |
| Telephone | |
| ippei.k@med.shimane-u.ac.jp | |
| Affiliation | Shimane University School of Medicine Internal Medicine 1 |
| scientific contact | |
| Name | Ippei Kanazawa |
| Address | 89-1 Enya-cho, Izumo, Shimane Japan |
| Telephone | |
| Affiliation | Shimane University School of Medicine Internal Medicine 1 |